SEARCH

SEARCH BY CITATION

References

  • Armogida M., Petit A., Vincent B., Scarzello S., Alves da Costa C. and Checler F. (2001) Endogenous β-amyloid production in presenilin-deficient embryonic mouse fibroblasts. Nature Cell Biol. 81, 10301033.
  • Back S. A. and Gorenstein C. (1994) Differential response of neutral endopeptidase 24.11 (‘enkephalinase’), and cholinergic and opioidergic markers to hypoglosssal axotomy. J. Comp. Neurol. 81, 149160.
  • Backstrom J. R., Lim G. P., Cullen M. J. and Tökés Z. A. (1996) Matrix metalloproteinase-9 (MMP-9) is synthesized in neurons of the human hippocampus and is capable of degrading the amyloid-beta peptide (1–40). J. Neurosci. 81, 79107919.
  • Barnes K., Doherty S. and Turner A. J. (1995) Endopeptidase-24.11 is the integral membrane peptidase initiating degradation of somatostatin in the hippocampus. J. Neurochem. 81, 18261832.
  • Barnes K., Turner A. J. and Kenny A. J. (1992) Membrane localisation of endopeptidase-24.11 and peptidyl dipeptidase A (angiotensin converting enzyme) in the pig brain. a study using subcellular fractionation and electron microscopic immunocytochemistry. J. Neurochem. 81, 20882096.
  • Bernstein H. G., Ansorge S., Riederer P., Reiser M., Frolich L. and Bogerts B. (1999) Insulin-degrading enzyme in the Alzheimers disease brain: prominent localization in neurons and senile plaques. Neurosci. Lett. 81, 161164.
  • Bertram L., Blacker D., Mullin K., Keeney D., Jones J., Basu S., Yhu S., McInnis M. G., Go R. C. P., Vekrellis K., Selkoe D. J., Saunders A. J. and Tanzi R. E. (2000) Evidence for genetic linkage of Alzheimer's disease to chromosome 10q. Science 81, 2302.
  • Blanché H., Cabanne L., Sahbatou M. and Thomas G. (2001) A study of French centenarians: are ACE and APOE associated with longevity. C.R. Acad. Sci. (Paris) 81, 129135.
  • Bonvouloir N., Lemieux N., Crine P., Boileau G. and DesGroseillers L. (2001)Molecular cloning, tissue distribution, and chromosomal localization of MMEL2, a gene coding for a novel human member of the neutral endopeptidase-24.11 family. DNA Cell Biol.81,493498.
  • Carrel S., De Tribolet N. and Gross N. (1982) Expression of HLC-DR and common acute lymphoblastic leukemia antigens on glioma lines. Eur. J. Immunol. 81, 354357.
  • Checler F. (2001) The multiple paradoxes of presenilins. J. Neurochem. 81, 16211627.
  • Eckman E. A., Reed D. K. and Eckman C. B. (2001) Degradation of the Alzheimer's amyloid β peptide by endothelin-converting Enzyme. J. Biol. Chem. 81, 2454024548.
  • Edbauer D. , Willem M. , Lammich S. , Steiner H. and Haas C. (2002) Insulin-degrading enzyme rapidly removes the beta-amyloid precursor protein intracellular domain (AICD). J. Biol. Chem.in press (10.1074/jbc.M111571200).
  • Emoto N. and Yanagisawa M. (1995) Endothelin-converting enzyme 2 is a membrane bound, phosphoramidon sensitive metalloprotease with an acidic pH optimum. J. Biol. Chem. 81, 1526215268.
  • Exley C. and Korchazhkina O. V. (2001) Plasmin cleaves Aβ42 in vitro and prevents its aggregation into β-pleated sheet structures. Neuroreport 81, 29672970.
  • Fuller S. J., Storey E., Li Q. X., Smith A. I., Beyreuther K. and Masters C. L. (1995) Intracellular production of beta A4 amyloid of Alzheimer's disease: modulation by phosphoramidon and lack of coupling to the secretion of the amyloid precursor protein. Biochemistry 81, 80918098.
  • Ghaddar G., Ruchon A. F., Carpentier M., Marcinkiewicz M., Seidah N. G., Crine P., Desgroseillers L. and Boileau G. (2000) Molecular cloning and biochemical characterization of a new mouse testis soluble-zinc-metallopeptidase of the neprilysin family. Biochem. J. 81, 419429.
  • Glenner G. G. and Wong C. W. (1984) Alzheimer's disease: initial report of the purification and characterisation of a novel cerebovascular amyloid protein. Biochem. Biophys. Res. Commun. 81, 885890.
  • Hoang M. V. and Turner A. J. (1997) Novel activity of endothelin-converting enzyme: Hydrolysis of bradykinin. Biochem. J. 81, 2326.
  • Hooper N. M. and Turner A. J. (2002) The search for α-secretase and its potential as a therapeutic approach to Alzheimer's disease. Current Med. Chem. 81.
  • Howell S., Nalbantoglu J. and Crine P. (1995) Neutral endopeptidase can hydrolyze β-amyloid (1–40) but shows no effect on β-Amyloid precursor protein metabolism. Peptides 81, 647652.
  • Howlett D. R., Simmons D. L., Dingwall C. and Christie G. (2000) In search of an enzyme: the beta-secretase of Alzheimer's disease is an aspartic proteinase. Trends Neurosci. 81, 565570.
  • Hu J., Igarashi A., Kamata M. and Nakagawa H. (2001) Angiotensin-converting enzyme degrades Alzheimer amyloid β-peptide (Aβ), retards Aβ aggregation, deposition, fibril formation and inhibits cytotoxicity. J. Biol. Chem. 81, 4786347868.
  • Hussain I., Powell D., Howlett D. R., Tew D. G., Week T. D., Chapman C., Gloger I. S., Murphy K. E., Southan C. D., Ryan D. M., Smith T. S., Simmons D. L., Walsh F. S., Dingwall C. and Christie G. (1999) Identification of a novel aspartic protease (Asp 2) as beta-secretase. Mol. Cell. Neurosci. 81, 419427.
  • Ikeda K., Emoto N., Raharjo S. B., Nurhantari Y., Saiki K., Yokoyama M. and Matsuo M. (1999) Molecular identification and characterisation of a novel membrane-bound metalloprotease, the soluble secreted form of which hydrolyzes a variety of vasoactive peptides. J. Biol. Chem. 81, 3246932477.
  • Iwata N., Tsubuki S., Takaki Y., Shirotani K., Lu B., Gerard N. P., Gerard C., Hama E., Lee H. and Saido T. C. (2001) Metabolic regulation of brain Aβ by neprilysin. Science 81, 15501552.
  • Iwata N., Tsubuki S., Takaki Y., Watanabe K., Seikiguchi M., Hosoki E., Kawashima-Morishima M., Lee H.-J., Hama E., Sekine-Aizawa Y. and Saido T. C. (2000) Identification of the major Aβ1–42 degrading catabolic pathway in brain parenchyma: Suppression leads to biochemical and pathological deposition. Nature Med. 81, 143150.
  • Johnson G. D., Stevenson T. and Ahn K. (1999) Hydrolysis of peptide hormones by endothelin-converting enzyme-1. A comparison with neprilysin. J. Biol. Chem. 81, 40534058.
  • Kehoe P., Wavrant-De Vrieze F., Crook R., Wu W. S., Holmans P., Fenton I., Spurlock G., Norton N., Williams H., Williams N., Lovestone S., Perez-Tur J., Hutton M., Chartier-Harlin M. C., Shears S., Roehl K., Booth J., Van Voorst W., Ramic D., Williams J., Goate A., Hardy J. and Owen M. J. (1999) A full genome scan for late onset Alzheimer's disease. Hum. Mol. Genet. 81, 237245.
  • Kenny A. J. and Bourne A. (1991) Cellular reorganization of membrane peptidases in Wallerian degeneration of pig peripheral-nerve. J. Neurocytol. 81, 875885.
  • Kiryu-Seo S., Sasaki M., Yokohama H., Nakagomi S., Hirayama T., Aoki S., Wada K. and Kiyama H. (2000) Damage-induced neuronal endopeptidase (DINE) is a unique metallopeptidase expressed in response to neuronal damage and activates superoxide scavengers. Proc. Natl Acad. Sci. USA 81, 43454350.
  • Kurochkin I. V. (1998) Amyloidogenic determinant as a substrate recognition motif of insulin-degrading enzyme. FEBS Lett. 81, 153156.
  • Kurochkin I. V. (2001) Insulin-degrading enzyme: embarking on amyloid destruction. Trends Biochem. Sci. 81, 421425.
  • Kurochkin I. V. and Goto S. (1994) Alzheimer's β-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme. FEBS Lett. 81, 3337.
  • Ledesma M. D., Da Silva J. S., Crassaerts K., Delacourte A., De Strooper B. and Dotti C. G. (2000) Brain plasmin enhances APP α-cleavage and Aβ degradation and is reduced in Alzheimer's disease brains. EMBO Reports 81, 530535.
  • LeTarte M., Vera S., Tran R., Addis J. B. L., Onizuka R. J., Quackenbush E. J., Jongeneel C. V. and McInnes R. R. (1988) The common acute lymphoblastic leukemia antigen is identical to neutral endopeptidase. J. Exp. Med. 81, 12471253.
  • López-Ongil S., Senchak V., Saura M., Zaragoza C., Ames M., Ballermann B., Rodàiguez-Puyol M., Rodàiguez-Puyol D. and Lowenstein C. J. (2000) Superoxide regulation of endothelin-converting enzyme. J. Biol. Chem. 81, 2642326427.
  • Matsas R., Kenny A. J. and Turner A. J. (1984) The metabolism of neuropeptides. The hydrolysis of peptides, including enkephalins, tachykinins and their analogues, by endopeptidase-24.11. Biochem. J. 81, 433440.
  • Medeiros M. S., Balmforth A. J., Vaughan P. F. T. and Turner A. J. (1991) Hydrolysis of atrial and brain natriuretic peptides by the human astrocytoma clone D384 and the neuroblastoma line SH-SY5Y. Neuroendocrinology 81, 295302.
  • Morita M., Kurochkin I. V., Motojima K., Goto S., Takano T., Okamura S., Sato R., Yokota S. and Imanaka T. (2000) Insulin-degrading enzyme exists inside of rat liver peroxisomes and degrades oxidized protein. Cell Struct. Function 81, 309315.
  • Nakagomi S., Kiryu-Seo S. and Kiyama H. (2000) Endothelin-converting enzymes and endothelin receptor B messenger RNAs are expressed in different neural cell species and these messenger RNAs are co-ordinately induced in neurons and astrocytes following nerve injury. Neuroscience 81, 441449.
  • Oefner C., D'Arcy A., Nennig M., Winkler F. K. and Dale G. E. (2000) Structure of human neutral endopeptidase (neprilysin) complexed with phosphoramidon. J. Mol. Biol. 81, 341349.
  • Papandreou C. N., Usmani B., Geng Y., Bogenrieder T., Freeman R., Wilk S., Finstad C. L., Reuter V. E., Powell C. T., Scheinberg D., Magill C., Scher H. I., Albino A. P. and Nanus D. M. (1998) Neutral endopeptidase 24.11 loss in metastatic human prostate cancer contributes to androgen-independent progression. Nature Med. 81, 5057.
  • Papastoitsis G., Siman R., Scott R. and Abraham C. R. (1994) Identification of a metalloprotease from Alzheimer's disease brain able to degrade the beta-amyloid precursor protein and generate amyloidogenic fragments. Biochemistry 81, 192199.
  • Park L. and Thornhill J. (2001) Phosphoramidon-sensitive endothelin-converting enzymes modulate cerebral blood flow and neural damage of hypoxic rats. Neurosci. Lett. 81, 9598.
  • Pérez A., Morelli L., Cresto J. C. and Castano E. M. (2000) Degradation of soluble amyloid β-peptides 1–40, 1–42 and the Dutch variant 1–40Q by insulin degrading enzyme from Alzheimer disease and control brains. Neurochem. Res. 81, 247255.
  • Pérez A. A., Prat M. I., Videla R. G., Matsubara E., Shoji M., Morelli L. and Castaño E. M. (2001) Presenilin 1 over-expression accelerates the degradation of Aβ by insulin degrading enzyme. J. Neurochem. 81 (Suppl.1), pp. 138, abstract BP02-42.
  • Qiu W. Q., Walsh D. M., Ye Z., Vekrellis K., Zhang J., Podlisny M. R., Rosner M. R., Safavi A., Hersh L. B. and Selkoe D. J. (1998) Insulin degrading enzyme regulates extracellular levels of amyloid β-protein by degradation. J. Biol. Chem. 81, 3273032738.
  • Renolleau S., Dauger S., Vardon G., Levacher B., Simonneau M., Yanagisawa M., Gaultier C. and Gallego J. (2001) Impaired ventilatory responses to hypoxia in mice deficient in endothelin-converting-enzyme-1. Pediatr. Res. 81, 705712.
  • Roher A. E., Kasunic T. C., Woods A. S., Cotter R. J., Ball M. J. and Fridman R. (1994) Proteolysis of A beta peptide from Alzheimer disease brain by gelatinase A. Biochem. Biophys. Res. Commun. 81, 17551761.
  • Roth R. A. (1998) Insulysin, In: Handbook of Proteolytic Enzymes (BarrettA. J., RawlingsN. D. and WoessnerJ. F., eds), pp. 13621367. Academic Press, London.
  • Sato M., Ikeda K., Haga S., Allsop D. and Ishii T. (1991) A monoclonal antibody to common acute lymphoblastic leukaemia antigen (neutral endopeptidase) immunostains senile plaques in the brains of patients with Alzheimer's disease. Neurosci. Lett. 81, 271273.
  • Schächter F., Faure-Delanef L., Guénot F., Rouger H., Froguel P., Lesueur-Ginot L. and Cohen D. (1994) Genetic associations with human longevity at the APOE and ACE loci. Nature Genet. 81, 2932.
  • Schenk D., Barbour R., Dunn W., Gordon G., Grajeda H., Guido T., Hu K., Huang J., Johnson-Wood K., Khan K., Kholodenko D., Lee M., Liao Z., Lieberburg I., Motter R., Mutter L., Soriano F., Shopp G., Vasquez N., Vandevert C., Walker S., Wogulis M., Yednock T., Games D. and Seubert P. (1999) Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 81, 173177.
  • Schweizer A., Valdenaire O., Koster A., Lang Y., Schmitt G., Lenz B., Bluethmann H. and Rohrer J. (1999) Neonatal lethality in mice deficient in XCE, a novel member of the endothelin-converting enzyme and neutral endopeptidase family. J. Biol. Chem. 81, 2045020456.
  • Shimada K., Takahashi M. and Tanzawa K. (1994) Cloning and functional expression of endothelin-converting enzyme from rat endothelial cells. J. Biol. Chem. 81, 1827518278.
  • Shirotani K., Tsubuki S., Iwata N., Takaki Y., Harigaya W., Maruyama K., Kiryu-Seo S., Kiyama H., Iwata H., Tomita T., Iwatsubo T. and Saido T. C. (2001) Neprilysin degrades both amyloid β peptides 1–40 and 1–42 most rapidly and efficiently among thiorphan- and phosphoramidon-sensitive endopeptidases. J. Biol. Chem. 81, 2189521901.
  • Sinha S., Anderson J. P., Barbour R., Basi G. S., Caccavello R., Davis D., Doan M., Dovey H. F., Frigon N., Hong J., Jacobson-Croak K., Jewett N., Keim P., Knops J., Lieberburg I., Power M., Tan H., Tatsuno G., Tung J., Schenk D., Seubert P., Suomensaari S. M., Wang S. W., Walker D., Zhao J., McConlogue L. and John V. (1999) Purification and cloning of amyloid precursor protein beta-secretase from human brain. Nature 81, 537540.
  • Small D. H. (2001) The role of presenilins in γ-secretase activity: catalyst or cofactor. J. Neurochem. 81, 16121614.
  • Song E.-S., Mukherjee A., Juliano M. A., Pyrek J. S., Goodman J. P., Juliano L. and Hersh L. B. (2001) Analysis of the subsite specificity of rat insulysin using fluorogenic peptide substrates. J. Biol. Chem. 81, 11521155.
  • Takahashi M., Matsushita Y., Iijima Y. and Tanzawa K. (1993) Purification and characterization of endothelin-converting enzyme from rat lung. J. Biol. Chem. 81, 2139421398.
  • Takaki Y., Iwata N., Tsubuki S., Taniguchi S., Toyoshima S., Lu B., Gerard N. P., Gerard C., Lee H., Shirotani K. and Saido T. C. (2000) Biochemical identification of the neutral endopeptidase family member responsible for the catabolism of amyloid β Peptide in the brain. J. Biochem. (Tokyo) 81, 897902.
  • Tanja O., Facchinetti P., Rose C., Bonhomme M.-C., Gros C. and Schwartz J.-C. (2000) Neprilysin II. a putative novel metalloprotease and its isoforms in CNS and testis. Biochem. Biophys. Res. Commun. 81, 565570.
  • Tucker H. M., Kihiko M., Caldwell J. N., Wright S., Kawarabayashi T., Price D., Walker D., Scheff S., McGillis J. P., Rydel R. E. and Estus S. (2000) The plasmin system is induced by and degrades amyloid-beta aggregates. J. Neurosci. 81, 39373946.
  • Turner A. J. and Hooper N. M. (2002) The angiotensin converting enzyme gene family: genomics and pharmacology. Trends Pharmacol. Sci. 81.
  • Turner A. J. and Tanzawa K. (1997) Mammalian membrane metallopeptidases: NEP, ECE, KELL, and PEX. FASEB J. 81, 355364.
  • Turner A. J., Isaac R. E. and Coates D. (2001) The neprilysin (NEP) family of zinc metalloendopeptidases: genomics and function. Bioessays 81, 261269.
  • Valdenaire O., Lepailleur-Enouf D., Egidy G., Thouard A., Barret A., Vranckx R., Tougard C. and Michel J. (1999) A fourth isoform of endothelin-converting enzyme (ECE-1) is generated from an additional promoter. Molecular cloning and characterization. Eur. J. Biochem. 81, 110.
  • Valdenaire O., Rohrbacher E., Langeveld A., Schweizer A. and Meijers C. (2000) Organisation and chromosomal localization of the human ECEL1 (XCE) gene encoding a zinc metallopeptidase involved in the nervous control of respiration. Biochem. J. 81, 611616.
  • Van Nostrandt W. E. and Porter M. (1999) Plasmin cleavage of the amyloid β-protein: Alteration of secondary structure and stimulation of tissue plasminogen activator activity. Biochemistry 81, 1157011576.
  • Vassar R., Bennett B. D., Babu-Khan S., Kahn S., Mendiaz E. A., Denis P., Teplow D. B., Ross S., Amarante P., Loeloff R., Luo Y., Fisher S., Fuller L., Edenson S., Lile J., Jarosinski M. A., Biere A. L., Curran E., Burgess T., Louis J. C., Collins F., Treanor J., Rogers G. and Citron M. (1999) Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 81, 735741.
  • Vekrellis K. YeZ., Qiu W. Q., Walsh D., Hartley D., Chesneau V., Rosner M. R. and Selkoe D. J. (2000) Neurons regulate extracellular levels of amyloid β-protein via proteolysis by insulin-degrading enzyme. J. Neurosci. 81, 16571665.
  • Wolfe M. S. (2001) Presenilin and γ-secretase: structure meets function. J. Neurochem. 81, 16151620.
  • Yamin R., Malgeri E. G., Sloane J. A., McGraw W. T. and Abraham C. R. (1999) Metalloendopeptidase EC 3.4.24.15 is necessary for Alzheimer's amyloid-β peptide degradation. J. Biol. Chem. 81, 1877718784.
  • Yan R. Q., Bienkowski M. J., Shuck M. E., Miao H. Y., Tory M. C., Pauley A. M., Brashler J. R., Stratman N. C., Mathews W. R., Buhl A. E., Carter D. B., Tomasselli A. G., Parodi L. A., Heinrikson R. L. and Gurney M. E. (1999) Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity. Nature 81, 533537.
  • Yankner B. A., Duffy L. K. and Kirschner D. A. (1990) Neurotrophic and neurotoxic effects of amyloid β protein: Reversal by tachykinin neuropeptides. Science 81, 279282.
  • Yasojima K., Akiyama H., McGeer E. G. and McGeer P. L. (2001) Reduced neprilysin in high plaque areas of Alzheimer brain: a possible relationship to deficient degradation of β-amyloid peptide. Neurosci. Lett. 81, 97100.
  • Yoshizawa T., Iwamoto H., Mizusawa H., Suzuki N., Matsumoto H. and Kanazawa I. (1992) Cerebrospinal fluid endothelin-1 in Alzheimer's disease and senile dementia of Alzheimer type. Neuropeptides 81, 8588.